Latest debt-to-equity ratio

Scribe Therapeutics Debt-to-equity ratio

Direct answer

Scribe Therapeutics's debt-to-equity ratio is 4.11%.

The verified market snapshot reports 4.11%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked November 19, 2026.

Get free Scribe Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
4.11%